Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DAP001494

Drug Information
NameMebeverine
Synonymsthoxy-.alpha.-methylphenethyl)amino]-, butyl ester-; Mebeverine (USAN)(*hydrochloride*); Spectrum5_001315; C25H35NO5; Mebeverina; 2753-45-9 (HYDROCHLORIDE); KBio1_000045; Mebeverinum; Prestwick3_000310; Arluy (TN); LS-162044; 4-(Ethyl(2-(4-methoxyphenyl)-1-methylethyl)amino)butyl 3,4-dimethoxybenzoate; Benzoic acid, 3,4-dimethoxy-, {4-[ethyl[2-(4-methoxyphenyl)-1-methylethyl]amino]butyl} ester; Veratric acid, 4-[ethyl(p-me; Mebeverina [INN-Spanish]; EINECS 222-830-4; Arluy; Spectrum3_000918; SPBio_002499; Mebeverine (INN); NINDS_000045; BRD-A09467419-003-04-2; Veratric acid, 4-((ethyl(p-methoxy-alpha-methylphenethyl))amino)butyl ester; 4-(ethyl{1-methyl-2-[4-(methyloxy)phenyl]ethyl}amino)butyl 3,4-bis(methyloxy)benzoate; Spectrum4_001017; KBio2_003483; 4-(ethyl-(4-methoxy-alpha-methylphenethyl)aminobutyl) veratrate; KBio2_000915; DivK1c_000045; BSPBio_000280; NSC169101; D08160; KBio2_006051; SPBio_001448; Spectrum2_001404; AB00053597; 4-[ethyl-[1-(4-methoxyphenyl)propan-2-yl]amino]butyl 3,4-dimethoxybenzoate; KBio3_001896; CHEMBL282121; Benzoic acid, 3,4-dimethoxy-, 4-(ethyl(2-(4-methoxyphenyl)-1-methylethyl)amino)butyl ester; BRN 2783282; Prestwick2_000310; Veratric acid, 4-((ethyl(p-methoxy-.alpha.-methylphenethyl))amino)butyl ester; KBioGR_001513; Prestwick0_000310; Benzoic acid, 3,4-dimethoxy-, 4-[ethyl[2-(4-methoxyphenyl)-1-methylethyl]amino]butyl ester; KBioSS_000915; CID4031; BPBio1_000308; Mebeverinum [INN-Latin]; Mebeverine [INN:BAN]; mebeverine; IDI1_000045; Prestwick1_000310; 3625-06-7; Spectrum_000435; AC1L1H9B
CompanyReckitt & Colman
IndicationIrritable bowel syndrome
[ICD9: 564.1   ICD10: K58]
Approved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C25H35NO5/c1-6-26(19(2)17-20-9-12-22(28-3)13-10-20)15-7-8-16-3
1-25(27)21-11-14-23(29-4)24(18-21)30-5/h9-14,18-19H,6-8,15-17H2,1
-5H3
InChIKeyVYVKHNNGDFVQGA-UHFFFAOYSA-N
Canonical SMILESCCN(CCCCOC(=O)C1=CC(=C(C=C1)OC)OC)C(C)CC2=CC=C(C=C2)OC    
CAS NumberCAS 3625-06-7
PubChem Compound IDCID 4031.
PubChem Substance IDSID 213763.
SuperDrug ATC IDA03AA04
SuperDrug CAS ID003625067;
TargetMuscarinic acetylcholine receptorAntagonist[1]
Ref 1Emerging drugs for irritable bowel syndrome. Expert Opin Emerg Drugs. 2006 May;11(2):293-313. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543